Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
2017The New International Congress on Anti-Cancer Treatment
Focus on Consensus and Guidelines for a better Practice
THE NEW ICACT
©H
ervé
Mic
haud
-MD
A P
AR
IS 2
016
International Medical Events19-21 rue Saint Denis - 92100 Boulogne-Billancourt Tél. : 00 33 (0)1 41 04 04 04 - Fax : 00 33 (0) 1 41 04 04 11
28, Avenue George V, 75008 ParisEUROSITES George V
21st - 23rd March 2017
Pré-
prog
ramme
Preli
mina
ry Pro
gram
Président : Jean-Philippe SPANO MD, PhD-Paris, France
www.icact.com
Dear friends,
The scientific committee and I are particularly honored to welcome you to Paris for ‘The New ICACT 2017!’ from 21st to 23rd March 2017.For the first time, a large number of Scientific Societies involved in the fight against cancer will be meeting to-gether to give you all the necessary information for your daily practice and give you the best medical training in Oncology. Many of the top international experts in the field of Oncology will also be present, thus contributing to very high-level discussions!
We look forward to these three days of oncology training being both friendly and highly constructive through their scientific exchanges, contributions and discussions.
We are particularly delighted to present new subjects such as medical-economic topics and sessions devoted to research and therapeutic education. We have also opened our doors this year to patients’ associations to give them the opportunity to exchange with professionals.
A special session devoted to recommendations on good practice will close the Congress, organized under the aegis of young oncologists, The National College of Oncology Professors and the French Cancer Society at the end of which the ‘Claude Jacquillat’ Prize will be awarded to one of them, in recognition of their work on a thesis or piece of scientific research, a demonstration of the profession’s support and an ex-pression of their congratulations.
This new organization of the Congress will be structured around multi-disciplinary ses-sions which will provide you from A to Z with all the information you need to care for your patients. We are also providing simultaneous interpreting so that every speaker may make their presentation in French or in English, as they prefer, thus meeting the expectations of all the participants.
We look forward to seeing as many of you as possible and sharing a very pleasant three days with you in March 2017! Please do not hesitate to talk about this Congress to your colleagues so that they also may attend to the ‘The New ICACT 2017!’
With our sincere thanks for your support.Jean-Philippe Spano, MD, PhD
International Medical Events (IME) 19-21 rue Saint Denis- 92100 Boulogne Billancourt – Web site : www.im-events.com - Email : [email protected] CommitteeCONTACT : Valérie CAILLON Tél : + 33 1 41 04 04 04 Fax : +33 1 41 04 04 11 Email : [email protected] Information & AccommodationContact : Mathilde MANGIN Tél : + 33 1 41 04 04 04 Fax : +33 1 41 04 04 11 Email : [email protected]
2017The New International Congress on Anti-Cancer TreatmentTHE NEW ICACT
2 3
AApro Matti, Genève, Switzerland
ABASTADo philippe, paris, France
ANDrE Fabrice, paris, France
ANToNI Delphine, Strasbourg, France
AyMArD Lydie, Marseille, France
AzrIA David, Montpellier, France
BArLESI Fabrice, Marseille, France
BAUCHETET Chantal, paris, France
BELLANGEr Agnès, paris, France
BENjAMIN robert, Houston, USA
BIBAULT jean-Emmanuel, paris, France
BLAy jean-yves, Lyon, France
BoNArDEL Gerald, Saint Denis, France
BoNvALoT Sylvie, paris, France
BoUILLET Thierry, paris, France
CArrIE Sylvie, paris, France
CArTroN Guillaume, Montpellier, France
CHAIBI pascal, Ivry/Seiner, France
CHAMpIAT Stéphane, villejuif, France
CHArrASSE Anne, Monaco, France
CHICHEr Marie-Elodie, paris, France
CoEFFIC David, reims, France
CorTES javier, Barcelona, Spain
CULINE Stéphane, paris, France
DENIS Fabrice, Le Mans, France
DEUTSCH Eric, villejuif, France
DIELENSEGEr pascale, paris, France
DoUArrE Michèle, paris, France
DoHoLLoU Nadine, Bordeaux, France
DoUILLArD jean-yves, Lugano, Switzerland
DUCrEUx Michel, villejuif, France
DUFrESNE Armelle, Lyon, France
DUTrEIx Marie, paris, France
ESpIE Natacha, paris, France
FLoqUET Anne, Bordeaux, France
FrEBoUrG Thierry, rouen, France (TBC)
FrEyEr Gilles, Lyon, France
GArD Claudine, paris, France
GEorGoULIAS vassilis, Crète, Greece
GILLIET Christophe, paris, France
GLIGorov joseph, paris, France
GoBErT Aurélien, paris, France
HArpEr peter, London, UK
HATAKE Kiyohiko, Tokyo, japan
HoArAU Giséle, paris, France
HorToBAGyI Gabriel, Houston, USA
HoUEDE Nadine, Nîmes, France
joLy C., Créteil, France
jUSTE pierre-Alexandre, paris, France
LAUNEy-vACHEr vincent, paris, France
LEBrET Thierry, Suresnes, France
LE CESNE Axel, villejuif, France
LorTHoLAry Alain, Nantes, France
LoUvET Christophe, paris, France (TBC)
MAHé Marc, Nantes, France
MAINGoN philippe, paris, France
MALKA David, villejuif, France
MANUEL Clara, paris, France
MArTy Michel, paris, France
MEjEAN Arnaud, paris, France
MEyEr Guy, paris, France
MILANo Gérard, Nice, France
MorErE jean-François, villejuif, France
MorNEx Françoise, Lyon, France
Moro-SIBILoT Denis, Grenoble, France
NAMAN Hervé, Mougins, France
NAMEr Moïse, Nice, France
NEUzILLET yann, Suresnes, France
pAUL MUrIEL, Créteil, France
pAUTIEr patricia, villejuif, France
pErEz Edith, jacksonville, USA
pIErGA jean-yves, paris, France (TBC)
pLoUSSArD Guillaume, Toulouse, France
pUjoL pascal, Montpellier, France
qUEvAL C., Créteil, France
rAFII Arash, Montpellier, France (TBC)
rAUCHETET Chantal, paris, France
rAy-CoqUArD Isabelle, Lyon, France
roUMIGUIE Mathieu, Toulouse, France
roUprET Morgan, paris, France
rozET François, paris, France
SCoTTé Florian, paris, France
SHEpHErD Frances, Toronto, Canada
SorIA jean-Charles, villejuif, France
SpANo jean-philippe, paris, France
SwAIN Sandra, washington, USA
TABErNEro josep, Barcelona, Spain
ToUBIANA Thierry, Marne-la-vallée, France
TroUSSIEr Idriss, paris, France
TSUjI yasushi, Sapporo, japan
vAN CUTSEM Eric, Leuven, Belgium
zAMBrowSKI jean-jacques, paris, France
The NeW INTerNaTIoNal ScIeNTIfIc commITTee
*In progress
2 3
ScIeNTIfIc SympoSIum oN prelImINary program ScIeNTIfIc SympoSIum oN prelImINary program
Conférence Multidisciplinaire d’oncologie / Multidisciplinary Oncology Conference /Consensus and Guidelines for a better practice
09:30 - 10:00 : Auditorium Accueil/Welcome
opening sessionjean-philippe SpANo, Gabriel HorToBAGyI
Bienvenue - Évaluation des connaissances / Knowledge assesment
Tuesday 21st March 2017 - 10:00 - 13:45 - AM
– AUDITORIUM – 12:30-13:45
4Déjeuner débatMédecine personnalisée :
intérêt du testing En partenariat avec le
laboratoire MSD France
– MILAN –
10:00-12:30 ActuAlItés sArcoME /
sArcoMA updAtE Sous l’égide du GSF-GETo
Biologie / AnAtoMopAthologie / néoAdjuvAnt / AdjuvAnt / nouvelles Molécules /
chirurgie / prAtique selon le type histologique
Présidents: Robert Benjamin,
Jean-Yves Blay & Axel le Cesne
Modérateur/Chaired by:Sylvie Bonvalot, Armelle Dufresne
• Armelle dufrEsnENew actionable targets in STS?
Nouveaux objectifs réalisables dans les STS (Sarcome des Tissus mous)?
• sylvie BonvAlotSurgery remains the cornerstone of treatment in resectable STS
La chirurgie reste la pierre angulaire du traitement des STS résécables
• Axel lE cEsnEImpact of peri-operative chemotherapy in localized STS of extremity/trunk wall
Impact de la chimiothérapie péri-opératoire dans les STS localisés des
extrémités/paroi thoracique
• Jean-Yves BlAYValue of networks of reference and
the forthcoming European Reference Networks
Intérêt des réseaux de référence et des futurs réseaux de référence
européens
• robert BEnJAMIn – Houston, USA
Unresolved questions in GIST Questions sans réponse dans les GIST
(tumeurs stromales gastro intestinales)
– CERCLE PRIVÉ –
10:00-12:30 cAncéro-nursEs /
MédIco-tEchs 09h00 : Accueil
10h : Introduction Gisèle Hoarau,
présidente de l’AFITCH-OR
Modérateurs :Michèle Douarre, cadre supérieur de de santé, GH Pitié Salpêtrière, Paris
Marie-Elodie Chicher, Coordonnatrice d’un 3c site intégré d’oncologie, GH
Pitié Salpêtrière, Paris
• Idriss troussIErradiothérapeute, gh pitié salpêtrière, paris
10h15 : Le principe de la curiethérapie
• MEr & IdEgh pitié salpêtrière, paris
10h45 : Complémentarité des rôles dans la prise en charge des patients en
curiethérapie
11h00 : PAUSE
• dr pascal chAIBIonco-gériatre,****ide,
hôpital charles-Foix, ivry/seine 11h30 : Prise en charge & évaluation
du patient en onco-gériatrie
12h30 – 14h Déjeuner
Modérateurs :Clara Manuel, cadre supérieur de santé, GH Pitié Salpêtrière, ParisSylvie Carrié, cadre supérieur de
santé, Institut Curie, Paris
• c. QuEvAl, cadre de santé • c. JolY, oncologue,
hôpital henri Mondor, créteil14h00 : Bénéfices pour le patient de
l’activité physique adaptée
14h45 : Programme d’éducation thérapeutique dans le cancer du sein
(IDE – Médecin, UIC, Curie, Paris)
15h30 : PAUSE
15h40 : Programme d’éducation thérapeutique à domicile – retour
d’expérience du Pas-de-Calais
16h15 : Film suivi d’une table ronde « Et si on parlait d’amour »
• Chantal BAuchEtEt vice-présidente de l’AFITCH-OR
16h45 : Conclusion
– AUDITORIUM –
10:00-12:30ActuAlItés cAncEr du
pouMon / lung cAncEr updAtE
Sous l’égide de l’IFCT et de la SpLF (GoLF)
Présidents:Fabrice Barlesi, Vassilis
Georgoulias, Denis Moro-Sibilot & Frances Shepherd
• fabrice BArlEsI – Marseille, France
WBRT, neo-and adjuvant, sequential and /or concomitant combo with RT
in NSCLC and SCLC. TBC
• frances shEphErd – Toronto, Canada
Immunotherapy and third generation targeted agents. TBC
• vassilis gEorgoulIAsHetrogeneity and dynamic value of
CTCs in SCLC
– PARIS –
10:00-12:30ActuAlItés cAncErs dIgEstIfs / gI tuMors
updAtESous l’égide d’Unicancer, du GErCor et de la FFCD
Présidents:David Malka, Josep Tabernero, Yasushi Tsuji & Eric Van Cutsem
Modérateur/Chaired by:Pierre Laurent-Puig TBC, Christophe Louvet TBC (new chairman of the
GERCOR group), Jean-François Seitz (chairman of the FFCD) TBC
• Josep tABErnEro – Barcelona, Spain New drugs and molecular taxonomy
of gastric and colon cancer Nouveaux traitements pharmacologiques
et taxonomie moléculaire des cancers gastriques et du côlon
• Eric vAn cutsEM – Leuven, Belgium TBD State of the art of metastatic colorectal
cancer: what do guidelines tell usOù en est-on en matière de
recommendations pour le traitement du cancer colorectal?
• Christophe louvEt (tBc)What is the state of the art
for pancreatic cancer? Traitement médical du cancer du pancréas : où en sommes-nous ?
Jean-françois sEItz (tBc) Talk by a FFCD member, talk title TBD
(on NETs?)Présentation par un membre de la FFCD,
sujet à déterminer (sur NETs?),or soit
• pierre lAurEnt-puIg (tBc)Biomarkers of metastatic colorectal
cancer Biomarqueurs du cancer colorectal
métastatique
• david MAlkABiliary cancers: a paradigm for
precision medicine, new hope offered by immunotherapy? Cancers biliaires :
paradigme pour la médicine de précision, nouvel espoir de l’immunothérapie ?
Take home messages (TBD) Message à retenir (orateur?)
• Yasushi tsuJI Promising New Strategy for Gastric Cancer with Peritoneal Metastases - Intraperitoneal Chemotherapy with
PaclitaxelNouvelle stratégie prometteuse pour
les cancers gastriques avec métastases péritonéales- Chimiothérapie
4 5
ScIeNTIfIc SympoSIum oN prelImINary program ScIeNTIfIc SympoSIum oN prelImINary program
Tuesday 21st March 2017 - 14:00 - 18:30 - pM
– PARIS –
16:30-17:30XclInIcAl sYMposIuM
– MILAN –
14:00-16:00lEs cAncérologuEs
prIvés - prIvAtE oncologIsts /
sEssIon IMMunothérApIE -
IMMunothErApY sEssIonSous l’égide du CroL
Présidents: Lydie Aymard, Nadine Dohollou, Hervé Naman & Thierry Toubiana
Modérateur/Chaired by:Delphine Antoni, Stéphane Champiat,
Guillaume Cartron, David Coeffic & Jean-Charles Soria
Introduction
• Jean-Charles sorIA – villejuif, france
Les outils thérapeutique de l’immuno-modulation
• guillaume cArtron -Montpellier, france
Principales indications actuelles et à ve-nir des immunothérapies anti-tumorales
• Stéphane chAMpIAt – villejuif, france
Les effets secondaires des immunothé-rapies anti-tumorales et leur prise en
charge
• Delphine ANTONI -strasbourg, france
Radiothérapie et immunothérapie anti-tu-morale
Discussion
– AUDITORIUM –
17:30-18:30Plénière table ronde /
Auditorium round table
controvErsE MédIco-écono-MIQuE / MédIco- EconoMIc IssuE
Président:Jean–Jacques Zambrowski
Modérateur/Chaired by:Natacha Espié (EUROPADONNA)
– AUDITORIUM –
14:00-16:00prévEntIon / vAccInAtIon
n 16:00-16:30 - Pause / Visite sur les stands / Break n
– PARIS –
14:00-16:00Session débat / Debate session
sEssIon sur lEs BIosIMIlAIrEs / sEssIon on
BIosIMIlArsQuId dEs BIosIMIlAIrEs
En onco-héMAtoAvec le soutien institutionnel du
Club Inter pharmaceutique
Modérateur/Chaired by:Agnès Bellanger, Claudine Gard,
Muriel Paul
• Muriel pAul - henri MondorGénése et actualité des biosimilaires
• claudine gArd - pitié-salpêtrière, rhumatologue TBD Interchangeabilité : retour d’expérience
• Agnès BEllAngEr, Muriel pAul, oncologue sénologue tBd,
hématologue TBDTable ronde: Les bonnes questions à se
poser avant le passage à l’acte
4 5
Wednesday 22nd March 2017 - 09:00 - 13:45 - AM
n 10:30-10:50 - Pause / visite sur les stands / break n
- MILAN -
09:00-12:30Apport dE lA génoMIQuE Et
BIoMArQuEurs prédIctIfs dE réponsEs/
WhAt dId WE lEArn froM sEQuEncIng Efforts ?
Président: Fabrice André
Modérateurs/Chaired by: Kiyohiko Hatake
& Mikhael Lichinitser
• kiyohiko hAtAkE – Tokyo, Japan
What did we learn from sequencing effort ? What we learn from lymphoma
genomics: …Can we change the standard care for high risk lymphoma?
- AUDITORIUM -
09:00-12:30ActuAlItés cAncEr
du sEIn / BrEAst cAncEr updAtE (1)
Sous l’égide du comité de St paul
Biologie / AnAtoMopAthologie / chirurgie / rAdiothérApie / triple
négAtiF
Modérateurs/Chaired by: Javier Cortes, Joseph Gligorov, Gabriel Hortobagyi, Moise Namer, Edith Perez
& Sandra Swain
• gabriel hortoBAgYI – houston, usA
Multi-gene assays for prognostication of early and relapse in primary breast
cancer
- PARIS -
09:00-12:30rAdIothérApIE :
lEs nouvEllEs ApprochEs tEchnIQuEs / AdvAncEs In rA-
dIAtIon oncologY
Sous l’Egide de la SFro
Présidents: David Azria, Philippe Maingon
& Françoise MornexModérateurs/Chaired by: Jean-Emmanuel Bibault, Eric Deutsch, Marc Mahé
• françoise MornEx 09h-9h30
Actualités en Stéréotaxie
• Philippe MAIngon9h30-10h
IRM accélérateur/cobalt : accélérateur de demain ?
• david AzrIA10h-10h30
Test prédictifs de radiosensibilité des tissus sains
pause
• Eric dEutsch11h – 11h30
Radiothérapie et Immunothérapie : de la préclinique aux
essais cliniques
• Marc MAhé11h30- 12h00
Les recommandations de la SFRO/SFPM : RECORAD
• Jean-Emmanuel BIBAult 12h-12h30
Les grands articles d’oncologie radiothérapie publiés en 2016
– AUDITORIUM – 12:30-13:45
4Déjeuner débatcancers du sein métastatique
rh+/her2- : vers un changement de référentiels ?
En partenariat avec le Laboratoire Pfizer
Modérateur : Jean-Philippe Spano
1) en 2017, quelles recommandations dans la prise en charge du cancer du sein
métastatique rh+/her2- ? orateur à confirmer
2) inhibiteurs de cdK4/6 : quelle avancée thérapeutique ? Véronique Dieras
3) inhibiteurs de cdK4/6 : quand et pour quelles patientes ? Nadine Dohollou
6 7
ScIeNTIfIc SympoSIum oN prelImINary program ScIeNTIfIc SympoSIum oN prelImINary program
- AUDITORIUM -17:30-18:30
« lA lEçon dE l’IcAct » « thE lEsson of IcAct »
- PARIS -
14:00-17:00soIns dE support / supportIvE cArE Sous l’égide de l’AFSoS
Présidents: Matti Aapro & Florian Scotté
Modérateur/chaired by: Philippe Abastado, Stéphane
Champiat, Fabrice Denis, Vincent Launey-Vacher & Guy Meyer
• florian scottéHighlights SOS-SPALL 2016
• Matti AApro Nausea Vomiting
• fabrice dEnIsFollow up and survival, new approach in
cancer course
• vincent lAunAY vAchErKidney, CKIN
• Philippe ABAstAdoGeneral Questions to the panel
• Stéphane chAMpIAtImmunotherapy, side effects
management and specificities (elderly…)
• guy MEYErThrombosis old and new drugs
• Philippe ABAstAdoHeart monitoring during and after
anticancer treatment
• Matti AAproGeneral Questions to the panel
and conclusion
Wednesday 22nd March 2017 -14:00 - 18:30 - pM
- MILAN -
14:00-16:30ActuAlItés sur lE cAncEr dE
l’ovAIrE / ovArIAn cAncErs updAtE
Sous l’égide du groupe GINECo
AnAtoMApAthologie / génétique / chirurgie / strAtégies
thérApeutiques
Présidente: Patricia Pautier
Modérateurs/Chaired by: Anne Floquet, Gilles Freyer, Peter
Harper, Pierre-Alexandre Juste, Alain Lortholary & Isabelle
Ray-Coquard
• Peter hArpEr – london, uk Molecular Pathology and New Targets in
Ovarian and Peritoneal Cancer
• Dr Alain lortholArY - nantes, france
Place de la consultation d’oncogénétique en oncologie gynécologie
• Pr Gilles frEYEr - lyon, france
Les inhibiteurs de Parp pour quelles patientes comment les prescrire
• Dr Anne floQuEt - Bordeaux, france
Point sur la prise en charge des récidives platine sensible des cancers de l’ovaire
• Pr Isabelle rAY-coQuArd *- lyon, france
Le réseau français des tumeurs rares de l’ovaire
• dr pierre-Alexandre JustE - paris, france
Mise à jour sur la classification moléculaire et pathologique des cancers
de l’endomètre
- AUDITORIUM -
14:00-16:30ActuAlItés cAncEr
du sEIn / BrEAst cAncEr updA-tE (2)
Sous l’égide du comité de St paul Présidents:
Joseph Gligorov, Gabriel Hortobagyi, Moïse Namer,
Edith Perez, Jean-Philippe Spano & Sandra Swain
her2+++ / rh+ the wAy we Are now
• Edith PEREZ – Jacksonville, USAPersonalized breast cancer management
in 2017
• gabriel hortoBAgYI – houston, usA
Advances in the treatment of luminal A and B breast cancers: primary and
metastatic
• sandra sWAIn – Washington, USAHER2 positive cancer in metastatic disease
- AUDITORIUM -16:30-17:30
IMMunologIE oncologIE : de la théorie à la pratique
IMMunologY oncologY: from theory to practice
Présidents:Agnès Bellanger, Anne Charrasse
Modérateur/Chaired by:Anne Charrasse, Gérard Milano
• Gérard MIlAno - cAl niceImmunothérapie : son évaluation et ses
facteurs de résistanceComment rendre vertueuse une RCP à
propos de l’immunothérapien 16:30-17:00 - Pause / visite sur les stands / break n
6 7
ScIeNTIfIc SympoSIum oN prelImINary program ScIeNTIfIc SympoSIum oN prelImINary program
ScIeNTIfIc SympoSIum oN prelImINary program ScIeNTIfIc SympoSIum oN prelImINary program
Thursday 23rd March 201709:00 - 12:30 - AM
n 12:30-14:00 - Cocktail déjeunatoire / cocktail lunch n
n 10:30-10:50 - Pause / visite sur les stands / break n
- MILAN -
09:00-12:30ActuAlItés cAncEr vEssIE/
prostAtE BlAddEr / prostAtE / cAncEr updAtE
Sous l’égide de l’AFU
Présidents: David Azria, Thierry Lebret, Arnaud
Méjean & Morgan Roupret
SESSION PROSTATE Modérateur/Chaired by:
David Azria & Thierry Lebret
09H-09H19 • guillaume ploussArd
Pertinence du dépistage du cancer de la prostate en 2017
09H20-09h49 • gerald BonArdEl
Imagerie moléculaire dynamique du cancer de la prostate
09h50-10H19 • françois rozEt
Intérêt du traitement local dans le cancer de la prostate oligo métastatique
pAUSE 25 minutes
SESSION VESSIE Modérateur/Chaired by:
Arnaud Méjean & Morgan Roupret
10h45-11H04 • Yann nEuzIllEt
Comment vivre avec une dérivation urinaire en 2017?
11H05-11h19 • Mathieu rouMIguIE
Chimiothérapie des tumeurs de la voie excrétrice urinaire supérieure
11h20-11h40 • nadine houEdE
Nouvelles Immunothérapies du cancer de la vessie
11H45-12H45 Clinical Symposium du
Laboratoire Ipsen « Actualités dans le cancer du rein »
-AUDITORIUM-
-09:00-12:30sport Et cAncEr / sport And cAncEr
Sous l’égide de la CAMI
Président: Thierry Bouillet
Comment favoriser le remboursement de l’activité physique en cancérologie ?
Dans quels lieux ? Avec qui ? Sous quelles modalités ?
- PARIS -
09:00-12:30
MédEcInE génoMIQuE : ApplIcAtIon En oncologIE /
génoMIcs: ApplIcAtIon In oncologY
Sous l’égide de la SFMpp
Président: Pascal Pujol
Modérateur/Chaired by: Jean-Yves Blay, Thierry Frebourg (TBC), Joseph Gligorov, Kiyohiko Hatake, Jean-Yves Pierga (TBC) &
Arash Rafii (TBC)
BRCA1/2: From predictive to personalized Medecine. Steven Narod or Marie-Claire
King (TBD)
• Thierry frEBourg (tBc) Sequençage nouvelle génération:
quelles applications en oncogénétique constitutionnelle?
• Arash rAfII (tBc) Analyses Pangénomiques Tumorales
• Jean-Yves BlAY (tBc) Comment accéder aux thérapies ciblées ? Programme Acsé, basket study et essais
cliniques
• Joseph glIgorov (tBc) Signatures génomiques dans le cancer du sein, de la prostate et du colon ADN
circulant
• Jean-Yves pIErgA (tBc) Valeur pronostique et prédictive. Etat des
connaissances et perspectives
• Kiyohiko hAtAkE – Tokyo, Japan Genomics: application in oncology, myeloma genomics and high risk
assessment…
8 9
ScIeNTIfIc SympoSIum oN prelImINary program ScIeNTIfIc SympoSIum oN prelImINary program
Thursday 23rd March 2017 13:00 - 17:00 - pM
- AUDITORIUM - 14:00-16:00
consEnsus Et guIdElInEshIghlIghts
Sous l’égide de l’AErIo, du Collège National des internes en oncologie, du Collège National des Enseignants en Cancérologie
et de La Société Française du Cancer
cAncer du sein / prostAte / pouMon / digestiF / vessie / prévention / éducAtion thérApeutique
BreAst cAncer / prostAte / lung / gi / BlAdder / prevention / therApeutic educAtion
Modérateurs/Chaired by the scientific committee AApro Matti, ABAstAdo philippe, Andre Fabrice, Antoni delphine, AyMArd lydie, AZriA david, BArlesi Fabrice, BAuchetet chantal, BellAnger Agnès, BenjAMin robert, BiBAult jean-emmanuel, BlAy jean-yves, BonArdel gerald, BonvAlot sylvie, Bouillet thierry, cArrie sylvie, cArtron guillaume, chAiBi pascal, chAMpiAt stéphane, chArrAsse Anne, chicher Marie-elodie, coeFFic david, cortes javier, culine stéphane, denis Fabrice, deutsch eric, dielenseger pascale, douArre Michèle, doholou nadine, douillArd jean-yves, ducreux Michel, duFresne Armelle, dutreix Marie, espie natacha (europAdonnA), Floquet Anne, FreBourg thierry (tBc), Freyer gilles, gArd claudine, georgouliAs vassilis, gilliet christophe, gligorov joseph, goBert Aurélien (président de l’Aerio), hArper peter, hAtAKe Kiyohiko, hoArAu gisèle (présidente de l’AFitch-or), hortoBAgyi gabriel, houede nadine, joly c. juste pierre-Alexandre, lAuney-vAcher vincent, leBret thierry, le cesne Axel, lortholAry Alain, louvet christophe, MAhé Marc, MAingon philippe, MAlKA david, MAnuel clara, MArty Michel, MejeAn Arnaud, Meyer guy, MilAno gérard, Morere jean-François, Mornex Francoise, Moro-siBilot denis, nAMAn hervé, nAMer Moise, neuZillet yann, pAul Muriel, pAutier patricia, pereZ edith, piergA jean-yves (tBc), ploussArd guillaume, pujol pascal, quevAl c., rAFii Arash (tBc), rAuchetet chantal, rAy-coquArd isabelle, rouMiguie Mathieu, roupret Morgan, roZet François, scotte Florian, shepherd Frances, soriA jean-charles, spAno jean-philippe, swAin sandra, tABernero josep, touBiAnA thierry, troussier idriss, tsuji yasushi, vAn cutseM eric, ZAMBrowsKi jean-jacques
• Jean-Yves douIllArd L’Echelle de Magnitude du Bénéfice Clinique de l’ESMO :
un outil d’aide à la décisionThe ESMO Magnitude of Clinical Benefit Scale (MCBS):
a tool for decision Right and Left Colon cancer: 2 different entities with Therapeutic implications,
the ESMO meta-analysis
- PARIS -
12:30 : Accueil13:00-17:00
sEssIon InfIrMIèrEs / nursEs sEssIon Sous l’égide de l’AFIC
Présidente: Pascale Dielenseger
- AUDITORIUM -
16:00-17:00Session des jeunes / Youth session 16h00-17h00
rEMIsE du prIx (clAudE JAcQuIllAt) / AWArd (thEsIs or MAstEr 2) postEr sEssIon
17:00 CLÔTURE / END
8 9
Submission Guidelines- Abstracts have to be submitted electronically and in English- Abstracts received after the deadline (February 5th, 2017) will not be considered- Supply as much information as possible: the precise subject of study, methods used where appropriate, summary of results obtained, conclusion- As it is assumed that original work will be presented, no bibliographic references are necessary- Selected abstracts will be published in the abstract book exactly as you submitted it. Therefore, proofreading is essential, no modification will be possible after submission.- Your abstract should not contain accents or any other invalid character, which would not be part of the English alphabet.- Your abstract’s text should not exceed 3,000 characters (excluding spaces)- The main author (presenter) confirms that all authors are aware of and agree to the content of the abstract and support of the data presented. By submitting his abstract, the author allows the 28th New ICACT to publish and distribute or sell his abstract as part of the Abstract Book, which may be distributed on paper.- All selected abstracts will be published in the abstract book. Papers accepted for poster presentation will be displayed during poster sessions.- Acceptance or rejection of the paper by the Scientific Committee will be notified by email to the main author (presenter) by February 13th, 2017- Only persons whose registration is complete will be able to present their abstracts- Posters will be awarded or encouraged: a special jury will select the three best posters and their authors will receive the SOMPS Poster Award and a cheque of 500E each.
Registration (Allows to access all satellite meetings of the New ICACT)
REGISTRATION FEES (in Euros) Regular Registration NURSE
From Oct. 15th 16 to Dec. 15th 2016 o 380 E o Free Registration
From Déc.. 16th 16 and on site o 450 E N° de formation : 11 75 459 05 75
*Provided signed Certificate from the school is attached to the registration form
Way of RegistRationOnline Registration: secure online registration and payment by credit card via the website www.icact.comRegistration will be validated only with payment by credit card (Visa, Mastercard).Registration Form sent by Fax or Mail:you can download the registration form on the website and send it duly completed to the Organisation Committee.Registration will be validated only with payment attached or credit card information completed.Cancellation PolicyBefore Décember 2nd, 2016 : 50% cancellation feesFrom November 3rd, 2016 : no refund
AbstractsSubmission Deadline:
February 5th, 2017
a
bs
tr
ac
t
2017The New International Congress on Anti-Cancer TreatmentTHE NEW ICACT
10 11
AccommodationSpeCIAl pRICeS hAve beeN NeGoTIATeD To oFFeR You The beST vAlue FoR The peRIoD boTh hoTelS ARe 3*** oR 4**** AND oFFeR The beST SITuATIoN :
CoNTACT uS FoR All ReSeRvATIoN ReQueST
PCOMedical Department
[email protected]. : 00 33 (0)1 41 04 04 04 / Fax : 00 33 (0) 1 41 04 04 11
19-21 rue Saint Denis - 92100 Boulogne-Billancourt
Booking only by Email : [email protected] or fax + 33 1 41 04 04 11 or post mailPlease fill the Registration Form
pAYMeNT AND AGReeMeNTDeadline Registration for hotel room:February 15th 2017Full payment upon registration
• From November 30th to december 30th, 2016: 50% cancellation fees• From January 1st to February 15th, 2017: 75% cancellation fees• From February 16th 2017: rooms cancelled are non refundable• Name changes are authorized till February 28th, 2017. (Any change or cancellation must be validated by mail or fax)
/1
• Plan d’accès
EUROSITES GEORGE V
28, AVENUE GEORGE V75008 PARIS 01 53 82 60 [email protected]
> METROLigne 1 : George VLigne 9 : Alma Marceau
> BUSLignes 32, 42, 63, 72, 73, 80 et 92
PRESENTATION - EUROSITES GEORGE V
euRoSITeS GeoRGe v28, AVENUE GEORGE V 75008 PARIS01 53 82 60 [email protected]
> METROLigne 1 : George VLigne 9 : Alma Marceau
> BUSLignes 32, 42, 63, 72, 73, 80 et 92
> PARkING Alma-Marceau George VChamps-Élysée
Pierre Ferran : 06 09 90 34 65
2017The New International Congress on Anti-Cancer TreatmentTHE NEW ICACT
10 11
EQU
ATO
UR
-IM
075
10
0360
RC
Par
is B
343
9036
3900
031
MASTER GLOBAL MEETING SP • SPP • 210 x 297 mm • Visuel: Global Meeting 19 • Remise le : 25/10 OM • Relecture
Whether you are the organiser or the participant, the Global Meetings Program allows you to benefi t
from the expertise of SkyTeam’s network covering over 1,000 destinations worldwide. Via the online
portal, not only can participants obtain discounted travel, but fl ights and connections are made more
convenient. Organisers can also take advantage of an online solution especially designed to meet their
needs, including a productivity reward program. Additionally, we provide you with a communications kit
and one point of contact to help manage your event. Visit our website www.skyteam.com/globalmeetings
MASTER GLOBAL MEETING SP • SPP • 210 x 297 mm • Visuel: Global Meeting 19 • Remise le : 25/10 OM • Relecture
Whether you are the organiser or the participant, the Global Meetings Program allows you to benefi t
from the expertise of SkyTeam’s network covering over 1,000 destinations worldwide. Via the online
portal, not only can participants obtain discounted travel, but fl ights and connections are made more
convenient. Organisers can also take advantage of an online solution especially designed to meet their
needs, including a productivity reward program. Additionally, we provide you with a communications kit
and one point of contact to help manage your event. Visit our website www.skyteam.com/globalmeetings
MASTER GLOBAL MEETING SP • SPP • 210 x 297 mm • Visuel: Global Meeting 19 • Remise le : 25/10 OM • Relecture
Whether you are the organiser or the participant, the Global Meetings Program allows you to benefi t
from the expertise of SkyTeam’s network covering over 1,000 destinations worldwide. Via the online
portal, not only can participants obtain discounted travel, but fl ights and connections are made more
convenient. Organisers can also take advantage of an online solution especially designed to meet their
needs, including a productivity reward program. Additionally, we provide you with a communications kit
and one point of contact to help manage your event. Visit our website www.skyteam.com/globalmeetings
GLOBAL MEETINGS PROGRAM - TICKETS PURCHASINGThe Discount Agreement will be for travel between March 16th through March 28th, 2017.
To benefit from these special offers, link up with http://globalmeetings.skyteam.com and quote the Identifier Code 3030S Tickets purchased on the following Carriers are eligible for the SkyTeam Global Meetings programme:
Aeroflot, Aerolíneas Argentinas, Aeroméxico, Air Europa, Air France, Alitalia, China Airlines, China Eastern, China Southern, Czech Airlines, Delta Air Lines, kenya Airways, kLM Royal Dutch Airlines, korean Air, Middle East Airlines, Saudia, TAROM, Vietnam Airlines
and Xiamen Air.
To book your travel now, visit www.skyteam.com/GlobalMeetings and enter your Event ID, 29 266 AF
AIR FARE DISCOUNT - Event ID : 29 266 AFSkyTeam Global Meetings Agreement - This Agreement is entered into by and among member airlines of the SkyTeam Alliance and EQUATOUR
The airlines of SkYTEAM, Official Alliance Network for 28th the New ICACT 2017, offer attractive airfares for participants.SkYTEAM comprises 19 leading international airlines serving 1000 destinations in 187 countries with over 15 000 flights daily.
Whether you are the organiser or the participant, the Global Meetings Program allows you to benefit from the expertise of SkyTeam’s network covering over 1,000 destinations worldwide. Via the online portal, not only can participants obtain discounted travel, but fl ights and connections are made more convenient. Organisers can also take advantage of an online solution especially designed to meet their needs, including a productivity reward program. Additionally, we provide you with a communications kit and one point of contact to help manage your event. Visit our website www.skyteam.com/globalmeetings
Through this site you can also access the schedules of all SkyTeam partners to plan your flights on the airline of your choice.
2017The New International Congress on Anti-Cancer TreatmentTHE NEW ICACT